DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 60 filers reported holding DERMA SCIENCES INC in Q4 2015. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $3,246,000 | +14.3% | 624,154 | +2.7% | 0.01% | +25.0% |
Q3 2016 | $2,839,000 | +4.5% | 608,004 | -11.8% | 0.00% | 0.0% |
Q2 2016 | $2,716,000 | +47.2% | 689,446 | +15.9% | 0.00% | +100.0% |
Q1 2016 | $1,845,000 | +5.1% | 595,005 | +54.9% | 0.00% | 0.0% |
Q4 2015 | $1,755,000 | +59.7% | 384,045 | +64.6% | 0.00% | +100.0% |
Q3 2015 | $1,099,000 | -43.3% | 233,389 | -13.9% | 0.00% | -50.0% |
Q2 2015 | $1,939,000 | -14.8% | 270,932 | +0.8% | 0.00% | -33.3% |
Q1 2015 | $2,277,000 | -46.9% | 268,814 | -41.6% | 0.00% | -50.0% |
Q4 2014 | $4,286,000 | -22.7% | 460,370 | -30.8% | 0.01% | -25.0% |
Q3 2014 | $5,543,000 | -26.5% | 665,437 | +2.0% | 0.01% | -27.3% |
Q2 2014 | $7,542,000 | +14.0% | 652,430 | +25.0% | 0.01% | 0.0% |
Q1 2014 | $6,615,000 | +69.7% | 521,755 | +44.8% | 0.01% | +83.3% |
Q4 2013 | $3,899,000 | +2685.0% | 360,395 | +3088.8% | 0.01% | – |
Q3 2013 | $140,000 | +2.2% | 11,302 | +10.7% | 0.00% | – |
Q2 2013 | $137,000 | – | 10,205 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,148,292 | $13,275,000 | 5.90% |
DAFNA Capital Management LLC | 384,794 | $4,448,000 | 4.22% |
Consonance Capital Management LP | 1,451,692 | $16,782,000 | 2.50% |
Broadfin Capital, LLC | 3,648,754 | $42,180,000 | 2.08% |
Redmile Group, LLC | 600,677 | $6,944,000 | 0.84% |
ORACLE INVESTMENT MANAGEMENT INC | 492,796 | $5,696,722,000 | 0.69% |
Senvest Management, LLC | 593,665 | $6,863,000 | 0.60% |
HealthCor Management, L.P. | 920,000 | $10,635,000 | 0.53% |
Baker Brothers Advisors | 3,537,137 | $40,889,000 | 0.50% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 112,117 | $1,296,000 | 0.50% |